Search results
Author(s):
Tobias Geisler
Added:
1 year ago
Author(s):
Julia Grapsa
,
Mirvat Alasnag
,
Barbara Casadei
Added:
1 year ago
What is the reasoning behind the porosity of data when it comes to CV outcomes in women?Diversity, Inclusion and Equity in Cardiology hosts, Dr Mirvat Alasnag (King Fahad Armed Forces Hospital, Jeddah, SA) and Dr Julia Grapsa (Guy's and St Thomas' NHS Foundation Trust, London, UK) are joined by Prof Barbara Casadei (British Heart Foundation, University of Oxford, Oxford, UK) who offers her advice…
View more
Added:
10 months ago
Source:
Radcliffe CVRM
A new study has explored the underlying mechanisms by which semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), improves outcomes in patients with metabolic dysfunction-associated steatohepatitis (MASH).¹ The research, which combined analysis of a phase 2 clinical trial with preclinical models, identified a unique proteomic signature associated with treatment and suggests that…
View more
Pulmonary Embolism Management
Author(s):
Andrew SP Sharp, Mantas Buitkus, Gilles Lemesle
Start date:
Oct 07, 2025
Broadcast
Maurizio Volterrani
Research Area(s) / Expertise:
Author
Expertise
Jolie Bruno
Author
Georgios Tsivgoulis
Research Area(s) / Expertise:
Author
Expertise
Gurleen Kaur
Job title: Cardiovascular Medicine Fellow
Author
Autophagy and Endoplasmic Reticulum Stress in HFpEF
Author(s):
Citrawati Dyah Kencono Wungu
,
Hendri Susilo
,
Cleodylon Reinard Susanto
,
et al
Added:
4 months ago
Review Article
Clinical Clues in Cardiovascular Disease
Video Series